טוען...

Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis

During the ongoing COVID-19 pandemic due to the SARS-CoV-2 virus of which evidence-based medical paradigms cannot be easily applied; difficult clinical decisions shall be required particularly in the 'difficult-to-treat' cases of high risk group with associated comorbidities. Convalescent...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Transfus Apher Sci
Main Authors: Çınar, Olgu Erkin, Sayınalp, Başak, Aladağ Karakulak, Elifcan, Avşar Karataş, Ayşe, Velet, Mustafa, İnkaya, Ahmet Çağkan, Ersoy Ortaç, Nazmiye Ebru, Öcal, Serpil, Aksu, Salih, Haznedaroğlu, İbrahim Celalettin, Sayınalp, Nilgün, Özcebe, Osman İlhami
פורמט: Artigo
שפה:Inglês
יצא לאור: Elsevier Ltd. 2020
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7258803/
https://ncbi.nlm.nih.gov/pubmed/32487513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.transci.2020.102821
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!